Skip to content

Analysis of gut microbiota characteristics and drug therapy associations in children with attention-deficit hyperactivity disorder

Analysis of gut microbiota characteristics and drug therapy associations in children with attention-deficit hyperactivity disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023239
Enrollment
Unknown
Registered
2019-05-18
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit hyperactivity disorder

Interventions

Healthy chidren group:no intervention

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ADHD group: the children are first diagnosed with ADHD by healthcare departmentof Children's Hospital of Chongqing Medical University according to DSM-IV, and the children take methylphenidate hydrochloride after the informed consent is obtained from their guardians. control group; the normal chidren.

Exclusion criteria

Exclusion criteria: ADHD group: ? with neurophysical diseases,mental retardation,anxiety,depression,serious cardiovascular disease, serious digestive system disease; ? acute and chronic infectious during the one month before taking methylphenidate hydrochloride and the period of taking methylphenidate hydrochloride; ? taking other medicines,especially antibiotics and microbial ecological agents; ? not continuous Administration of methylphenidate hydrochloride during one month; ? dietary(related to gut microbiota).

Design outcomes

Primary

MeasureTime frame
gut microbiota;

Countries

China

Contacts

Public ContactChen Li

Children’s Hospital of Chongqing Medical University

chenli2012@126.com+86 13677620103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026